In the coming weeks, a single drug will revolutionize the U.S. pharmaceutical industry. Zarxio, a drug that reduces infections caused by chemotherapy, is about to become the very first biosimilar drug sold in the United States.
Best practices, conversations and community engagement activities must continue to improve and adjust to the changing dynamics of an increasingly diverse population.
In a perspective piece recently published in Academic Medicine, my coauthors and I argue that our nation's leading AHCs, and the federal programs that support them, must make fundamental changes -- both in how they provide care and how they train the next generation of health care professionals -- to provide the kind of leadership our health care system needs now.
It's been five years since the Patient Protection and Affordable Care Act (PPACA, also called Obamacare) was signed into law. Implementation has occurred in stages over the last few years, but many business owners still have questions about how the law will continue to affect them.
As the Supreme Court prepares to decide the future of the ACA, the conversation has focused on the potential impact of the outcome. Specifically, that striking down federal subsidies for policy holders could create a nation of haves and have nots -- those with coverage and those without.
While we know how much insurers and oil and gas companies dole out to political campaigns and lobbyists, we don't have a clue how much of their cash is used to establish front groups or how much of it winds up in the pockets of either pundits for hire or tax-exempt organizations that do their bidding.
In my junior year at the University of North Carolina at Chapel Hill, a team of four Health Policy and Management classmates and I set out to understa...
One can argue that the private insurance industry should be regarded as obsolete and not worth saving. However, the ACA has extended its life, including almost $2 trillion in federal subsidies over the next ten years.
House Republicans want to convert Medicare into a voucher program, and would like to see the Senate concur. All this ties together as the biggest threat to health care for seniors and the disabled that we have yet seen. Democrats need to discover their spine!
Having assessed in the last three posts the impacts of the Affordable Care Act (ACA) over the last five years, we have seen that the ACA will not bring universal access, contain health care costs for patients and taxpayers, or improve the quality of care.
Many people who struggle with stress, mental illness or sub-optimal mental health lack the time and finances to engage in weekly therapy or ongoing me...
The Latino National Health and Immigration Survey provides some of the most comprehensive data on Latinos' attitudes toward and interactions with the Affordable Care Act at this important period in the law's history. We provide some of the key findings from this important survey specific to the ACA.
Five years ago, President Barack Obama signed the Affordable Care Act into law. What is crystal clear today is that the ACA, which I proudly call Obamacare, is working.
Health care is a human right and fundamental for a moral society. The ACA and its many provisions are important steps on our journey to health justice, a path that requires all of us (healthcare providers, elected officials, public health experts, and "ordinary" people) to do our part for our fellow Americans.
One way for Aetna to satisfy Wall Street was to begin shifting more and more of the cost of health care -- and health insurance -- to their customers. That meant that sick policyholders in particular would be paying more out of their own pocket for their care. Our marketing folks came up with an almost Orwellian name for this cost shifting: "consumer-driven health care."
America is on the cusp of becoming a nation with two health care systems. This sharp division is the result of continued resistance to the Affordable Care Act (ACA), and it does greatest harm to residents where the resistance is greatest.